awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35563524-2A027924-101B-4CAD-AD79-31BC6AC08194
Q35563524-2A027924-101B-4CAD-AD79-31BC6AC08194
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35563524-2A027924-101B-4CAD-AD79-31BC6AC08194
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
P2860
Q35563524-2A027924-101B-4CAD-AD79-31BC6AC08194
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35563524-2A027924-101B-4CAD-AD79-31BC6AC08194
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a65f18b35c589085fdba992eddead2f5a418940
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.